DCOY — Decoy Therapeutics Inc.

—
Nasdaq · Health Care · Pharmaceuticals · CIK 1615219 ·
Last close
$0.95
Market Cap
$2.26M
52W High
$16.92
52W Low
$0.83
ADV30
58,729
Next earnings
—
Decoy Therapeutics Inc. operates as a pre-clinical stage biotechnology company. It focuses on advancing the peptide conjugate therapeutics through its Immediate Peptide/PPMO/P-PROTAC Alpha-helical Conjugate Technology (IMP3ACT) platform that leverages peptide coiled-coils chemistry and physics to design a-helical peptides through computational and ML tools. The company's IMP3ACT platform leverages machine learning and artificial intelligence tools alongside synthesis techniques to engineer, enhance, and manufacture peptide conjugates targeting various unmet medical needs. It focuses on building a portfolio of peptide conjugate therapeutics focusing on infectious diseases and oncology. The company was formerly known as Salarius Pharmaceuticals, Inc. and change its name to Decoy Therapeutics Inc. in January 2026. Decoy Therapeutics Inc. is based in Houston, Texas.

Quarterly Fundamentals

Revenues vs Net Income (last 4 Q)

Assets vs Liabilities (last 4 Q)

PeriodRevenuesGross profitOp incomeNet incomeAssetsCashLiabilities
Jun 2026 0 — -2,403,392 -2,373,800 9,001,160 8,289,108 4,680,254
Mar 2026 0 — -2,283,739 -2,224,628 8,423,275 7,820,608 4,545,890
Dec 2025 0 — -9,034,562 -8,977,655 11,056,707 10,709,937 5,167,738
Sep 2025 0 — -895,130 -873,467 6,097,032 4,809,680 1,848,967

Cashflow TTM (yfinance, fills SEC gap)

Operating CF
$-8,324,525
Investing CF
$764,735
Financing CF
$15,096,436
CapEx
—
Dividends Paid
—
Buybacks
—
EPS Diluted TTM
$-111.57
As of
2026-11-15

Balance + Analyst (yfinance extras)

Retained Earnings
$-99,040,526
Inventory
—
Receivables
$200,000
ST Investments
—
EBIT TTM
$-14,616,823
Pretax Income TTM
$-14,449,550
Interest Exp TTM
—
Analysts
1

Yahoo Snapshot (yfinance, live)

Total Revenue
$227,629
EBITDA
$-6,074,362
Free Cash Flow
$-509,881
Enterprise Value
$-7,597,888
Total Cash
$8,289,108
Total Debt
$0
Shares Out
2,385,282
Trailing EPS
$12.74
Book Value
$11.07
ROE
-827.8%
ROA
-73.3%
Div Yield
0.00%

Annual Trend (SEC EDGAR, last 4y)

Revenues vs Net Income (last 4y)

FY endRevenuesOp incomeNet incomeAssetsLiabilitiesEquityOp cash flow
Dec 2025 0 -12,613,952 -12,518,480 11,100,000 5,167,738 5,888,969 -4,827,188
Dec 2024 0 -5,734,316 -5,575,777 3,022,974 1,511,279 1,511,695 -4,525,337
Dec 2023 0 -12,894,944 -12,542,693 6,586,523 1,299,241 5,287,282 -12,846,137
Dec 2022 0 -22,975,231 -31,607,956 14,650,799 4,266,191 10,384,608 -17,595,321

TTM Snapshot

Revenues TTM
$227,629
NetIncome TTM
$-14,449,550
OpCashFlow TTM
—
Assets (Latest)
$9,001,160
Forward EPS
$-8.28

Peers — same industry

TickerNameMarket CapLastDaily %
PRFX PRF Technologies Ltd. $2.31M $0.66 —
REVB REVELATION BIOSCIENCES, INC. $2.21M $3.88 —
BDRX Biodexa Pharmaceuticals Plc $2.20M $2.14 —
CVSI CV Sciences, Inc. $2.17M $0.01 —
RDHL RedHill Biopharma Ltd. $2.13M $0.35 —

News headlines (Yahoo Finance, 1h cache)

Decoy Therapeutics: Q3 Earnings Snapshot
2026-11-12 22:55 · Yahoo
Decoy Therapeutics Named “R&D Solution of the Year” in 2026 BioTech Breakthrough Awards
2026-11-10 14:47 · Yahoo
Decoy Therapeutics Provides Third Quarter 2026 Business Update
2026-11-03 12:15 · Yahoo
Decoy Therapeutics to Present at The Small Cap Showcase
2026-09-30 12:30 · Yahoo
Decoy Therapeutics Reports Preclinical Data Supporting Once-Weekly Intranasal Dosing for DCOY-CoV Program
2026-09-29 11:30 · Yahoo
Decoy Therapeutics, Inc. Issues Correction to Warrant Inducement Transaction Press Release
2026-09-22 22:14 · Yahoo
/C O R R E C T I O N -- Decoy Therapeutics, Inc/
2026-09-22 18:03 · Yahoo
Decoy Therapeutics Exploring Pan-Filovirus Program via FDA Animal Rule Pathway and Non-Dilutive Funding
2026-09-22 11:30 · Yahoo
Decoy Therapeutics to Present at the Moody Capital Solutions 2026 Disruptive Growth & Life Sciences Conference
2026-09-08 13:00 · Yahoo
Decoy Therapeutics Stockholders Elect Patricia Gauthier to Board of Directors
2026-07-15 13:24 · Yahoo

Recent Insider Activity

No insider activity indexed for this ticker.